Sign in

CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company

Cytosorbents Corp

Sign in to watch
Ticker
CTSO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
980373793
Phone
973-329-8885
Business address
305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
MedaSorb Technologies CORP, GILDER ENTERPRISES INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award Chief Financial Officer acquired 43,000 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award President and CEO acquired 60,000 shares (grant or award)
  6. 4 Open-market buy Chief Financial Officer bought 3,000 shares at $3.68 ($11,030)
  7. 4 Open-market buy President and CEO bought 16,500 shares at $3.60 ($59,400)
  8. 4 Open-market buy Chief Financial Officer bought 1,000 shares at $4.27 ($4,270)
  9. 4 Option exercise President and CEO acquired 75,000 shares (option exercise)
  10. 4 Open-market buy Chief Financial Officer bought 6,500 shares at $4.83 ($31,395)
  11. 4 Option exercise Chief Operating Officer acquired 4,600 shares (option exercise)
  12. 4 Option exercise Chief Medical Officer acquired 5,000 shares (option exercise)
  13. 3/A Insider 3/A
  14. 4 Open-market buy Chief Financial Officer bought 1,500 shares at $5.52 ($8,273)
  15. 4 Derivatives Options or other derivatives
  16. 4 Grant or award Chief Operating Officer acquired 54,100 shares (grant or award)
  17. 4 Grant or award Chief Medical Officer acquired 12,200 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Grant or award President and CEO acquired 60,000 shares (grant or award)

Page 7 of 20 · 395 filings